Switch to:
Haemonetics Corp (NYSE:HAE)
EV/EBITDA
58.06 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Haemonetics Corp's enterprise value is $2,342.9 Mil. Haemonetics Corp's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $40.4 Mil. Therefore, Haemonetics Corp's EV/EBITDA ratio for today is 58.06.

HAE' s EV/EBITDA Range Over the Past 10 Years
Min: 7.1   Max: 61.4
Current: 58.07

7.1
61.4

During the past 13 years, the highest EV/EBITDA Ratio of Haemonetics Corp was 61.40. The lowest was 7.10. And the median was 12.10.

HAE's EV/EBITDA is ranked lower than
89% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.51 vs. HAE: 58.07 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Haemonetics Corp's stock price is $39.91. Haemonetics Corp's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $-1.16. Therefore, Haemonetics Corp's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Haemonetics Corp's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=2342.909/40.352
=58.06

Haemonetics Corp's current Enterprise Value is $2,342.9 Mil.
Haemonetics Corp's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was -38.454 (Dec. 2015 ) + 16.64 (Mar. 2016 ) + 14.663 (Jun. 2016 ) + 47.503 (Sep. 2016 ) = $40.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Haemonetics Corp's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=39.91/-1.16
=

Haemonetics Corp's share price for today is $39.91.
Haemonetics Corp's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was -1.17 (Dec. 2015 ) + -0.17 (Mar. 2016 ) + -0.2 (Jun. 2016 ) + 0.38 (Sep. 2016 ) = $-1.16.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Haemonetics Corp Annual Data

Mar07Mar08Mar09Mar10Mar11Mar12Mar13Mar14Mar15Mar16
ev2ebitda 10.3013.1010.4610.649.3711.0919.9115.1520.4545.13

Haemonetics Corp Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda 15.5616.6817.5220.4518.1913.8731.0945.1350.6552.42
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK